#enlivex

Enlivex Therapeutics (ENLV), an Israel-based clinical-stage biotech firm, said it’s raising $212 million in a private placement to become the first publicly traded U.S. company to adopt a blockchain-based prediction markets token as its main treasury reserve asset. The token, RAIN, powers a decentralized protocol built on the Arbitrum blockchain that allows users to create and trade predictions…